Cliff Asness's AQST Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 201,941 shares of Aquestive Therapeutics, Inc. (AQST) worth $840,075, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 12 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in AQST, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 150,347 shares. Largest reduction occurred in Q2 2025, reducing 70,270 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Aquestive Therapeutics (AQST) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aquestive Therapeutics (AQST) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +150,347 | Add 291.40% | 201,941 | $4.16 |
| Q1 2026 | -10,115 | Reduce 16.39% | 51,594 | $4.15 |
| Q4 2025 | +3,934 | Add 6.81% | 61,709 | $6.46 |
| Q3 2025 | -974 | Reduce 1.66% | 57,775 | $5.59 |
| Q2 2025 | -70,270 | Reduce 54.46% | 58,749 | $3.31 |
| Q1 2025 | +14,025 | Add 12.20% | 129,019 | $2.90 |
| Q4 2024 | -15,806 | Reduce 12.08% | 114,994 | $3.56 |
| Q3 2024 | +130,800 | New Buy | 130,800 | $4.98 |
| Q2 2021 | -19,786 | Sold Out | 0 | $0.00 |
| Q4 2020 | +776 | Add 4.08% | 19,786 | $5.36 |
| Q3 2020 | +19,010 | New Buy | 19,010 | $4.84 |
Cliff Asness's Aquestive Therapeutics Investment FAQs
Cliff Asness first purchased Aquestive Therapeutics, Inc. (AQST) in Q3 2020, acquiring 19,010 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Aquestive Therapeutics, Inc. (AQST) for 12 quarters since Q3 2020.
Cliff Asness's largest addition to Aquestive Therapeutics, Inc. (AQST) was in Q2 2026, adding 201,941 shares worth $840,075.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 201,941 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $840,075.
As of the Q2 2026 filing, Aquestive Therapeutics, Inc. (AQST) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Aquestive Therapeutics, Inc. (AQST) was 201,941 shares, as reported at the end of Q2 2026.